EADO Congress

5 posters presented

Bhatia, N., Rigel, D., Armstrong, A., Schlesinger, T., Berman, B., Del Rosso, J., Kircik, L., Lebwohl, M., Patel, V. A., Narayanan, S., Koscielny, V., & Kasujee, I. (2023). Effectiveness and skin photodamage among patients with Actinic Keratosis receiving tirbanibulin 1% in routine clinical practices (PROAK Study). Presented at 19th EADO Congress. April 20th-22nd, 2023. Rome, Italy.

 

Lebwohl, M., Schlesinger, T., Patel, V. A., Del Rosso, J., Berman, B., Rigel, D., Armstrong, A., Bhatia, N., Kircik, L., Narayanan, S., Koscielny, V., & Kasujee, I. (2023). Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). Presented at 19th EADO Congress. April 20th-22nd, 2023.Rome, Italy.

 

Kircik, L., Rigel, D., Lebwohl, M., Schlesinger, T., Armstrong, A., Berman, B., Bhatia, N., Del Rosso, J.,   Patel, V. A., Narayanan, S., Koscielny, V., & Kasujee, I. (2023). Impact of tirbanibulin 1% treatment on symptoms, emotions, and functioning (measured by Skindex-16) of patients with Actinic Keratosis in routine clinical practices across the U.S. (PROAK Study). Presented at 19th EADO Congress. April 20th-22nd, 2023. Rome, Italy.

 

Schlesinger, T., Kircik, L., Del Rosso, J., Rigel Patel, V. A., Kircik, L., Armstrong, A., Berman, B., Bhatia, N., Lebwohl, M., Rigel, D., Narayanan, S., Koscielny, V., & Kasujee, I. (2023). Patient and clinician satisfaction (measured by TSQM-9) with the use of tirbanibulin in the treatment of Actinic Keratosis in routine clinical practices, and likelihood to consider tirbanibulin again (PROAK study). Presented at 19th EADO Congress. April 20th-22nd, 2023. Rome, Italy.

 

Berman, B., Lebwohl, M., Rigel, D., Schlesinger, T., Patel, V. A., Bhatia, N.,Del Rosso, J., Kircik, L., Armstrong, A., Narayanan, S., Koscielny, V., & Kasujee, I. (2023). Patient- and clinician-reported satisfaction with tirbanibulin to improve cosmetic outcomes in patients with actinic keratosis: an observational design (PROAK study). Presented at 19th EADO Congress. April 20th-22nd, 2023. Rome, Italy.

To request more information, send us an email at info@avant-health.com

Copyright © 2020 Avant Health. All rights reserved.